Education
About Us
Working with TipRanks
Follow Us
Rosetta Genomics (ROSGQ)
:ROSGQ
| Dec 16 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 9.23M |
| Gross Profit | $ 1.79M |
| Operating Income | $ -15.66M |
| EBITDA | $ -15.32M |
| Net Income | $ -16.23M |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 6.16M |
| Total Assets | $ 11.96M |
| Total Debt | $ 3.79M |
| Net Debt | $ -2.37M |
| Total Liabilities | $ 7.54M |
| Stockholders' Equity | $ 4.42M |
| Cash Flow | |
| Free Cash Flow | $ -10.59M |
| Operating Cash Flow | $ -10.37M |
| Investing Cash Flow | $ 823.00K |
| Financing Cash Flow | $ 3.26M |
Rosetta Genomics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.